MedTrace Logo

Genetic Diversity of Toxoplasma Gondii in Cancer Patients

NCT04834076 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-01-13

No results posted yet for this study

Summary

I. Evaluation of T. gondii infection in cancer patients using different serological markers.

II. Studying genetic lineages infecting cancer patients in Sohag Governorate to predict clinical course and therapeutic needs using B1 and RE genes.

Conditions

  • Toxoplasma Gondii Infection
  • Cancer

Interventions

DIAGNOSTIC_TEST

ELISA

ELISA is is a test that detects and measures toxoplasma IgG and IgM antibodies in blood.

DIAGNOSTIC_TEST

PCR

Polymerase chain reaction (PCR) is a method widely used to rapidly make millions to billions of copies of a specific DNA sample, allowing scientists to take a very small sample of DNA and amplify it to a large enough amount to study in detail.

DIAGNOSTIC_TEST

Sequencing

DNA sequencing is a laboratory technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Eman FF Mohammed, Ass lecturer · Sohag University

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-01-30
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04834076 on ClinicalTrials.gov